Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Jacques Rajter

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Chest|July 11, 2021
ResponseJuliana Cepelowicz-Rajter, Jean-Jacques Rajter, Michael Sherman
Chest|May 9, 2021
ResponseJean-Jacques Rajter, Juliana Cepelowicz Rajter, Michael Sherman
Chest|October 16, 2020
Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019: The Ivermectin in COVID Nineteen StudyJuliana Cepelowicz Rajter, Michael S Sherman, Naaz Fatteh, et al.
Pharmaceutics|September 27, 2025
A Pilot, Randomised, Placebo-Controlled, Double-Blind Trial of a Single Oral Dose of Ivermectin for Post-Exposure Prophylaxis of SARS-CoV-2Kylie M Wagstaff, Mark S Stein, Alan Herschtal, et al.
Reviews in Cardiovascular Medicine|January 3, 2021
Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)Peter A McCullough, Paul E Alexander, Robin Armstrong, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Chest|July 11, 2021
ResponseJuliana Cepelowicz-Rajter, Jean-Jacques Rajter, Michael Sherman
Chest|May 9, 2021
ResponseJean-Jacques Rajter, Juliana Cepelowicz Rajter, Michael Sherman
Chest|October 16, 2020
Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019: The Ivermectin in COVID Nineteen StudyJuliana Cepelowicz Rajter, Michael S Sherman, Naaz Fatteh, et al.
Pharmaceutics|September 27, 2025
A Pilot, Randomised, Placebo-Controlled, Double-Blind Trial of a Single Oral Dose of Ivermectin for Post-Exposure Prophylaxis of SARS-CoV-2Kylie M Wagstaff, Mark S Stein, Alan Herschtal, et al.
Reviews in Cardiovascular Medicine|January 3, 2021
Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)Peter A McCullough, Paul E Alexander, Robin Armstrong, et al.
Pageof 1